United Asset Strategies’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$164K Hold
209,608
0.01% 256
2026
Q1
$127K Hold
209,608
0.01% 252
2025
Q4
$201K Buy
209,608
+25,000
+14% +$35.4K 0.02% 257
2025
Q3
$321K Hold
184,608
0.03% 219
2025
Q2
$386K Buy
184,608
+100
+0.1% +$192 0.03% 203
2025
Q1
$315K Buy
184,508
+300
+0.2% +$1.13K 0.03% 207
2024
Q4
$930K Sell
184,208
-34,100
-16% -$169K 0.09% 139
2024
Q3
$1.19M Hold
218,308
0.11% 131
2024
Q2
$1.05M Sell
218,308
-3,300
-1% -$17.2K 0.1% 135
2024
Q1
$689K Buy
221,608
+300
+0.1% +$1.01K 0.07% 176
2023
Q4
$629K Buy
221,308
+77,500
+54% +$199K 0.07% 177
2023
Q3
$421K Sell
143,808
-40,152
-22% -$133K 0.05% 186
2023
Q2
$526K Buy
183,960
+125,000
+212% +$451K 0.07% 170
2023
Q1
$182K Buy
58,960
+31,500
+115% +$89.6K 0.02% 214
2022
Q4
$57.9K Buy
27,460
+12,500
+84% +$38K 0.01% 220
2022
Q3
$49K Hold
14,960
0.01% 201
2022
Q2
$48K Hold
14,960
0.01% 201
2022
Q1
$106K Buy
14,960
+4,650
+45% +$27.1K 0.01% 204
2021
Q4
$75K Buy
10,310
+2
+0% +$20 0.01% 204
2021
Q3
$120K Buy
+10,308
New +$118K 0.02% 196

Other funds holding HUMA

United Asset Strategies's HUMA Position: Q2 2026 in Review

United Asset Strategies held its Humacyte (HUMA) position steady in Q2 2026 at 209,608 shares worth $164K. The position accounts for 0.01% of the portfolio, ranked #256.

United Asset Strategies first reported a position in HUMA in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.19M in Q3 2024. 34 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • United Asset Strategies held 209,608 shares of Humacyte worth $164K as of Q2 2026.
  • United Asset Strategies left its Humacyte share count unchanged in Q2 2026.
  • Humacyte made up 0.01% of United Asset Strategies's portfolio in Q2 2026, its #256 holding.
  • United Asset Strategies first reported a position in Humacyte in Q3 2021 and has held it in 20 quarters since.
  • United Asset Strategies's Humacyte position peaked at $1.19M in Q3 2024.
  • 34 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on United Asset Strategies's 13F filing for Q2 2026, filed 13 Jul 2026.